1. sayfa ve
Tekrarlanan kayıtlar tek bir kaynakta birleştirilmektedir.
1
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Covid-19 COVID-19 Pandemic: An Unseen’s Evolution War Covid-19
2
Dergi Makalesi

Dergi Makalesi

Kaynak
1:
Kaynak
2:
Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19
3
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19-associated encephalopathy: Neurological manifestation of COVID-19 Coronavirus disease 2019 (
COVID-
19) is a viral disease, also known as severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China COVID-
19-associated neurological manifestations have not been widely reported. In this report, we describe a case of encephalopathy in a patient with
COVID-
19 infection. Covid-19
4
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 solution Some CoVs have recently entered humans from infected animals and lastly we have SARS
COVID-
19, (CoV), which causes severe acute, often fatal respiratory sars covid-19
5
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Why COVID-19? Covid-
19 has been estimated to have a case fatality rate of around 3%. In late December 2019, an outbreak of
COVID-
19 was reported from Wuhan city, China. Today
COVID-
19 has affected more than 212 countries and has made billions of people to be quarantined in their houses.
6
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Fighting COVID-19 Abstract The current
COVID-
19 pandemic caused by the novel coronavirus (SARS-CoV2) poses a threat to global health owing to its high rate of spread and covid-19
7
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 reflections
8
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Asymptomatic COVID-19 Infection Management: The Key to Stop COVID-19 The
COVID-
19 disease, emerged in December 2019, has spread rapidly, with new cases confirmed in multiple countries. portion of the population to virus and increase the late diagnosis and thereafter enhance
COVID-
19 mortality. Thereafter, it is fundamental to review our
COVID-
19 screening approach and enlarge
COVID-
19 testing to the general population by using rapid testing appliances COVID-19
9
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Decolonising COVID-19
10
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19: Immunopathogenesis Coronavirus-
19 disease (
COVID-
19) first described in Wuhan, China at the end of 2019. respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks may help to elucidate the pathogenesis of
COVID -
19.
11
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Forecasting COVID-19 COVID-19
12
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Pandemia COVID-19
13
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19: rethinking risk
14
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID 19: Neuromuscular manifestations COVID-
19 pandemic is ongoing and information on the neurological aspects of this viral infection is being gathered. This manuscript studies the available information on the neuromuscular manifestations of
COVID-
19. covid-19 neurological manifestations covid-19 neuromuscular manifestations
15
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19 in Brazil
16
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 and hypertension
17
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Cannabinoids and COVID-19 involved in immune function, the effect of cannabinoid intake on infectious conditions is questioned for several years and is of particular interest in the
COVID 19 pandemia. covid-19
18
Dergi Makalesi

Dergi Makalesi

Kaynak
1:
Kaynak
2:
Yazar(lar) :
Yıl :
2020
Epidemiology of COVID-19 COVID-
19, an infectious respiratory illness caused by the severe acute respiratory syndrome–corona virus 2 (SARS-CoV2), has now spread to multiple countries This review of the epidemiology of
COVID-
19 summarizes the burden of infection, transmission dynamics, and other related epidemiological features. Delivering health care for both
COVID-
19 affected individuals, as well those with other acute and chronic conditions, with limited access to healthcare covid-19
19
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Pharmacists and COVID-19 Abstract In the fight against
COVID-
19, frontline health workers have been vital to keeping the pandemic at bay, but recognition of individual professions -
19 treatments, and contributing to
COVID-
19 screening. Amid
COVID-
19, pharmacists have not stopped working as frontline workers and they should be recognized as such. COVID-19
20
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Post-COVID-19 spending
21
Dergi Makalesi

Dergi Makalesi

Yıl :
2020
AIDE-MEMOIRE COVID-19
22
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Comorbidities and COVID-19
23
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Tobacco and COVID-19 Similar data have been approved found for coronavirus disease-2019 (
COVID-
19) pandemic. adverse effects of tobacco and tobacco products and to raise awareness among the public and to make efforts to smoking on every opportunity during the
COVID -
19 pandemic. covid-19
24
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19: a review The enduring epidemic outbreak which started in Wuhan city of China, in December 2019 caused by the 2019 novel coronavirus (
COVID-
19) or the severe acute A highly virulent and pathogenic
COVID-
19 viral infection with incubation period ranging from two to fourteen days, transmitted by breathing of infected Approximately 1,016,128 reported cases, 211,615 recovered cases and 53,069 deaths of
COVID-2019 have been reported to date (April 2, 2020). COVID-19
25
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Coagulopathy and COVID-19 Caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), coronavirus disease 2019 (
COVID-
19) is a potentially fatal disease as a global The aim of this article is to review the potential mechanisms of coagulopathy in
COVID-
19 in light of literature data. covid-19
26
Dergi Makalesi

Dergi Makalesi

Kaynak
1:
Kaynak
2:
Yazar(lar) :
Yıl :
2020
Pathogenesis of COVID-19 The coronavirus disease 2019 (
COVID-
19) is a very contagious infectious disease which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV The aim of this report is to review the immunopathogenesis of
COVID-
19 in the light of current literature. covid-19
27
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19: Apocalypse Now?
28
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19 and globalization
29
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 in children Coronavirus disease-2019 (
COVID-
19) has affected nearly 2 million people and caused up to 100,000 people death worldwide until today. It should be kept in mind that
COVID-
19 may cause severe illness in infants under 1 year old and in children with chronic diseases such as chronic kidney Fever and cough are the most common symptoms in
COVID-
19, and children can also be asymptomatic. Laboratory findings are variable in children.
30
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Covid-19 and Neurology Coronavirus disease-
19 (
COVID-
19) pandemic is a new and important burden for the neurological area. mechanisms of neurological involvement of the disease may be explained more efficiently by neurologists who are included within the multidisciplinary
COVID -
19 teams. covid-19
31
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Astma and COVID-19 Asthma represents no increased risk in terms of catching the coronavirus disease-2019 (
covid-
19), and no report has been published to date associating Covid-
19, as with all other respiratory infections, interferes with control of asthma. In conclusion,
covid-
19 does not constitute a greater risk to patients with asthma.
32
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 and epilepsy
33
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Coping with COVID-19 Antivirals, specifically Remdesivir has been a strong candidate for the treatment of
COVID-
19. However, it has yet to receive universal acceptance for the treatment of
COVID-
19. These findings suggest the hypothesis that anti-malarial drugs have efficacy in the treatment of
COVID-
19. COVID 19
34
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19 Tapuya Reflection
35
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Smoking and COVID-19
36
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Resiliencia y Covid 19
37
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19 and publishing
38
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China Background: Faced with the coronavirus disease 2019 (
COVID-
19) pandemic, the development of
COVID-
19 vaccines has been progressing at an unprecedented of vaccines against
COVID-
19 during the pandemic. -
19 vaccination or valuing doctor’s recommendations could increase the probability of accepting
COVID-
19 vaccination as soon as possible, while having COVID-19
39
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Stand on the Same Side Against Covid – 19 Clinical Management of Covid-19 Covid-19
40
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19 Case Management Coronavirus disease (
COVID-
19) was first reported to the World Health Organization (WHO) on 31 December 2019 from Wuhan province of China as a cluster COVID-
19 is caused by SARS-CoV-2 virus which is a member of coronaviruses.
41
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 Neurological Manifestations
42
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19 and Indonesia Coronavirus disease 2019 (
COVID-
19) pandemic is an ongoing problem in more than 200 countries in the world. Indonesia has been greatly affected by
COVID-
19 with case fatality rate (CFR) being 8.9% in the end of March 2020. Demand of health system is likely to grow since the number of
COVID-
19 case is likely to rise. covid-19
43
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
More eyes on COVID-19: Perspectives from Philosophy: How philosophy bears on COVID-19 COVID-19
44
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
The dilemma of being non COVID-19 hospital in the era of COVID-19
45
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID 19: Relationship of the epidemiological pattern of COVID-19 between China and Italy The study aimed to analyze the epidemiological pattern of
COVID-
19 between Italy and China. The question that guided the review was: What were the epidemiological factors that led to the expression of
COVID-
19 between China and Italy? Further, more in-depth studies are needed regarding the harmful effects of chronic diseases as risk factors for
COVID-
19 infection.
46
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19: A BALINESE VIEWPOINT covid-19
47
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Telemedicina rural e COVID-19 COVID-19.